News
-
Bluebirdbio Announces The Lifting Of FDA Clinical Hold for Sickle Cell Disease And β-Thalassaemia Studies
bluebird bio, Inc. today announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical holds on the Phase 1/2 HGB-206 and Phase 3 HGB-210 studies of LentiGlobin…
Read More » -
US STUDY: COVID-19 Does Not Pose A Threat To Blood And Transfusion Safety
A new reassuring US study, published recently in the journal Transfusion, suggests that the risk of transmission of SARS-CoV2 through blood transfusion is highly unlikely. For the study, the investigators…
Read More » -
Chinese Sinovac COVID-19 Vaccine Approved By World Health Organization
The World Health Organization (WHO) announced yesterday that it has approved a COVID-19 vaccine made by Sinovac Biotech (SVA.O) for emergency use listing, paving the way for a second Chinese shot…
Read More » -
-
TIF Declares Support For Patent Waiver On COVID-19 Vaccines
In the midst of the raging COVID-19 pandemic, US President Joe Biden openly supported the World Trade Organization’s (WTO) proposal to lift the proprietary limits on COVID-19 vaccines, in service…
Read More » -
New Paper From Blood and Beyond Outlines How To Learn From The Impact Of The COVID-19 Crisis On Blood Use
The multi-stakeholder Blood and Beyond initiative recently published a policy briefing shedding light on how the COVID-19 pandemic affects blood use, blood transfusion services, and patients in whom transfusions are…
Read More » -
Ali Sattarpour: ”Thalassaemia did not stop me from living a normal life”
In occasion of the International Thalassaemia Day 2021, Ali Sattarpour, 45, France, Fédération SOS GLOBI Vice President and TIF’s Thalassaemia Patient Advocacy Group (T-PAG) Member, recounts a life of struggles,…
Read More » -
WHO Director General Dr Tedros Adhanom to address TIF’s Global Thalassaemia Review High-level Event
In celebration of the International Thalassaemia Day 2021, the Thalassaemia International Federation (TIF) proudly presents a High-level Event for the Official Premiere of the Federation’s Global Thalassaemia Review, to take…
Read More » -
International Thalassaemia Day 2021: Official Global Press Release
On International Thalassaemia Day, TIF shines a light on the striking health inequalities that affect the global thalassaemia community, further accentuated by the ongoing coronavirus pandemic. NICOSIA, May 5, 2021/Thalassaemia International…
Read More » -
Silence Therapeutics Launches New Video Game to Support ITD 2021 & Raise Disease Awareness
Silence Therapeutics partners with Thalassaemia International Federation (TIF) to support May 8th – International Thalassaemia Day activities. Silence Therapeutics plc, a leader in the discovery, development and delivery of novel…
Read More »